Factors associated with blood loss during radical prostatectomy for localized prostate cancer in the prostate-specific antigen (PSA)-era: an overview of the department of defense (DOD) Center for Prostate Disease Research (CPDR) national database

By Moul J.W.   Sun L.   Wu H.   McLeod D.G.   Amling C.   Lance R.   Foley J.   Sexton W.   Kusuda L.   Chung A.   Soderdahl D.   Donahue T.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 6, 2003-11 ,pp. : 447-455

Elsevier

Access to resources Recommend Favorite

Introduction to Department of Defense Center for Prostate Disease Research Multicenter National Prostate Cancer Database, and analysis of changes in the PSA-era

By Sun L.   Gancarczyk K.   Paquette E.L.   McLeod D.G.   Kane C.   Kusuda L.   Lance R.   Herring J.   Foley J.   Baldwin D.   Bishoff J.T.   Soderdahl D.   Wu H.   Xu L.   Moul J.W.  

Urologic Oncology: Seminars and Original Investigations, Vol. 6, Iss. 5, 2001-09 ,pp. : 203-209

Elsevier

Access to resources Recommend Favorite

Plasma insulin-like growth factor-1 and binding protein-3 and subsequent risk of prostate cancer in the PSA era

By Platz Elizabeth   Pollak Michael  

Cancer Causes and Control, Vol. 16, Iss. 3, 2005-04 ,pp. : 255-262

Springer Publishing Company

Access to resources Recommend Favorite

Changes in fPSA level could discriminate tPSA flare-up from tPSA progression in patients with castration-refractory prostate cancer during the initial phase of docetaxel-based chemotherapy

By Du Jun   Yang Qing   Chen Xu-Sheng   Tian Jie   Yao Xin  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 5, 2013-11 ,pp. : 1055-1061

Springer Publishing Company

Access to resources Recommend Favorite

Clinical Evaluation of Free PSA/Total PSA (Prostate-specific Antigen) Ratio in the Diagnosis of Prostate Cancer

By Filella X.   Alcover J.   Molina R.   Rodriguez A.   Carretero P.   Ballesta A.M.  

European Journal of Cancer, Vol. 33, Iss. 8, 1997-07 ,pp. : 1226-1229

Elsevier

Access to resources Recommend Favorite